Brief Research Report
Published on 21 Feb 2023
Numaswitch, a biochemical platform for the efficient production of disulfide-rich pepteins
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1082058
- 4,612 views
- 1 citation
156 Publications
volumes
Volume 3 - 2023
Original Research
Published on 10 Feb 2023
HMM-based profiling identifies the binding to divalent cations and nucleotides as common denominators of suramin targets
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1112992
- 2,476 views
Original Research
Published on 08 Feb 2023
Identification of novel genetic variants, including PIM1 and LINC01491, with ICD-10 based diagnosis of pulmonary arterial hypertension in the UK Biobank cohort
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1127736
- 5,502 views
- 9 citations
Original Research
Published on 20 Jan 2023
In silico identification of potential inhibitors of acyl carrier protein reductase and acetyl CoA carboxylase of Plasmodium falciparum in antimalarial therapy
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1087008
- 4,669 views
- 9 citations
Volume 2 - 2022
Original Research
Published on 12 Jan 2023
The use of cyclic peptide antigens to generate LRP8 specific antibodies
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1093153
- 4,921 views
- 4 citations
Brief Research Report
Published on 09 Jan 2023
Determination of nucleoside DOT1L inhibitors’ residence times by τRAMD simulations
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1083198
- 2,905 views
- 3 citations
Brief Research Report
Published on 05 Jan 2023
Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1082065
- 4,560 views
- 8 citations
Editorial
Published on 05 Jan 2023
Editorial: Insights in silico methods and artificial intelligence for drug discovery: 2022
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1126955
- 2,880 views
- 3 citations
Original Research
Published on 23 Dec 2022
Discovery of novel spike/ACE2 inhibitory macrocycles using in silico reinforcement learning
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1085701
- 2,830 views
- 4 citations
Methods
Published on 19 Dec 2022
Enhanced utility of AI/ML methods during lead optimization by inclusion of 3D ligand information
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1074797
- 10,100 views
- 11 citations
Review
Published on 15 Dec 2022
Novel and emerging therapies in pulmonary arterial hypertension
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1022971
- 14,299 views
- 11 citations
Original Research
Published on 12 Dec 2022
In silico mapping of the dynamic interactions and structure-activity relationship of flavonoid compounds against the immune checkpoint programmed-cell death 1 pathway
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1032587
- 5,286 views
- 5 citations
Mini Review
Published on 08 Dec 2022
Zingiber officinale (Ginger) as a treatment for inflammatory bowel disease: A review of current literature
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1043617
- 13,015 views
- 8 citations
Review
Published on 07 Dec 2022
The landscape of nature-derived antimalarials-potential of marine natural products in countering the evolving Plasmodium
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1065231
- 5,165 views
- 8 citations
Review
Published on 06 Dec 2022
Coumarin-1,2,3-triazole hybrids as leading-edge anticancer agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1072448
- 8,491 views
- 21 citations
Original Research
Published on 29 Nov 2022
ASK120067 (limertinib) exerts pre-clinical anti-tumor activity by inhibiting EGFR exon20 insertion
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1050687
- 3,596 views
- 3 citations
Mini Review
Published on 03 Nov 2022
Oxidized phospholipids are biomarkers, drug targets, and drug leads
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1043708
- 5,276 views
- 12 citations
Review
Published on 02 Nov 2022
Artificial intelligence for antiviral drug discovery in low resourced settings: A perspective
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1013285
- 8,778 views
- 16 citations
Original Research
Published on 25 Oct 2022
Network pharmacology and molecular docking to explore Siraitia grosvenorii’s potential mechanism in preventing and treating proliferative diabetic retinopathy
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1038224
- 3,008 views
- 2 citations
Systematic Review
Published on 25 Oct 2022
Characterization of KLH-driven immune responses in clinical studies: A systematic review
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.992087
- 13,338 views
- 7 citations
Review
Published on 21 Oct 2022
Nine receptors and binding proteins, four drugs, and one woman: Historical and personal perspectives
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1001487
- 3,519 views
- 5 citations
Original Research
Published on 21 Oct 2022
A machine learning-based virtual screening for natural compounds capable of inhibiting the HIV-1 integrase
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.954911
- 6,759 views
- 12 citations
Original Research
Published on 20 Oct 2022
From drugs to targets: Reverse engineering the virtual screening process on a proteomic scale
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.969983
- 7,116 views
- 13 citations
Original Research
Published on 18 Oct 2022
Plasma brain injury markers are associated with volume status but not muscle health in heart failure patients
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1042737
- 2,369 views
- 2 citations